A detailed history of Steward Financial Group LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Steward Financial Group LLC holds 72 shares of BMRN stock, worth $4,566. This represents 0.0% of its overall portfolio holdings.

Number of Shares
72
Holding current value
$4,566
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 20, 2023

BUY
$85.07 - $94.48 $6,125 - $6,802
72 New
72 $6,000
Q1 2023

May 05, 2023

BUY
$87.74 - $117.27 $3,597 - $4,808
41 Added 124.24%
74 $7,000
Q4 2022

Feb 13, 2023

BUY
$80.93 - $108.63 $2,670 - $3,584
33 New
33 $3,000
Q2 2022

Jul 22, 2022

BUY
$71.48 - $86.85 $1,286 - $1,563
18 New
18 $1,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $11.8B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Steward Financial Group LLC Portfolio

Follow Steward Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Financial Group LLC with notifications on news.